4-hydroxy-2-oxoglutarate metabolism in a mouse model of Primary Hyperoxaluria Type 3

Authors:

Abstract
No abstract available
Funding Information
  • NIDDK (K08DK115833)
  • Oxalosis and Hyperoxaluria Foundation
  • Alnylam Pharmaceuticals
  • National Institutes of Health (K01DK114332)

This publication has 15 references indexed in Scilit: